Morningstar Investor users sign in here.

Company Profile

  • Business description

    With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

  • Contact

    Novo Alle 1
    Bagsvaerd 2880
    DNK

    T: +45 44448888

    E: phak@novonordisk.com

    https://www.novonordisk.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    66,015

Novo Nordisk A/S News & Analysis

funds

Wirecard scandal: Should fund managers bet big?

Fund managers are urged to have the courage of their convictions, but the scandal around the German payments provider shows how that approach can go wrong.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,121.30 100.40 1.25%
CAC 40 8,239.99 14.20 0.17%
DAX 40 18,869.36 152.94 0.82%
Dow JONES (US) 39,908.00 349.89 0.88%
FTSE 100 8,445.80 17.67 0.21%
HKSE 19,073.71 41.35 -0.22%
NASDAQ 16,742.39 231.21 1.40%
Nikkei 225 38,609.16 223.43 0.58%
NZX 50 Index 11,658.78 132.90 1.15%
S&P 500 5,308.15 61.47 1.17%
S&P/ASX 200 7,854.90 101.20 1.31%
SSE Composite Index 3,119.51 0.39 -0.01%

Market Movers

Name
Last price
Change
% Change
PYC Therapeutics Ltd PYC 0.10 0.01 -4.76%
Sayona Mining Ltd SYA 0.05 0.00 -1.06%
Pantoro Ltd PNR 0.09 0.01 7.41%
Nine Entertainment Co. Holdings Ltd NEC 1.57 0.01 0.64%
PSC Insurance Group Ltd PSI 6.02 0.00 0.00%
Incitec Pivot Ltd IPL 2.93 0.11 3.72%
Pilbara Minerals Ltd PLS 3.98 0.01 -0.13%
Red 5 Ltd RED 0.48 0.01 2.66%
Resolute Mining Ltd RSG 0.48 0.03 5.49%
Strike Energy Ltd STX 0.23 0.02 -7.14%